Biogen Idec 2013 Annual Shareholder Meeting Webcast
WESTON, Mass. -- June 4, 2013
Biogen Idec Inc. (NASDAQ: BIIB) announced today that its 2013 Annual
Shareholder Meeting will be webcast live on Wednesday, June 12, 2013 at 9:00
a.m. ET. To access the live webcast, please visit Biogen Idec’s Investors
section at www.biogenidec.com. An archived version of the webcast will be
available following the meeting.
About Biogen Idec
Through cutting-edge science and medicine, Biogen Idec discovers, develops and
delivers to patients worldwide innovative therapies for the treatment of
neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in
1978, Biogen Idec is the world’s oldest independent biotechnology company.
Patients worldwide benefit from its leading multiple sclerosis therapies, and
the company generates more than $5 billion in annual revenues. For product
labeling, press releases and additional information about the company, please
Karen Jewell, 781-464-2442
Press spacebar to pause and continue. Press esc to stop.